One Pager as on May 31, 2026
![]() | Rule based diversification for optimum performance in changing market cycles |
![]() | Aim to provide stability of large caps and growth of mid caps |
![]() | Active stock selection through internal process framework for better return potential |
| Sector | MMLMCF* | NIFTY Large Midcap 250 TRI |
| Financial Services | 31.76% | 30.05% |
| Healthcare | 12.98% | 7.45% |
| Automobile And Auto Components | 7.76% | 6.88% |
| Capital Goods | 7.10% | 9.66% |
| Oil Gas & Consumable Fuels | 4.99% | 5.97% |
*Mahindra Manulife Large & Mid Cap Fund
Data as on May 31, 2026
| Security | % to Net Assets |
| ICICI Bank Limited | 3.76% |
| HDFC Bank Limited | 3.09% |
| IndusInd Bank Limited | 2.62% |
| Axis Bank Limited | 2.60% |
| The Federal Bank Limited | 2.54% |
| Reliance Industries Limited | 2.50% |
| Glenmark Pharmaceuticals Limited | 2.33% |
| Bharat Heavy Electricals Limited | 2.30% |
| Eternal Limited | 2.15% |
| Indus Towers Limited | 2.11% |
| Total | 26.00% |
| Fresh Additions | Complete Exits |
| Security | Security |
| Global Health Limited | - |
| Sai Life Sciences Limited | - |
| - | - |
Note: The companies/stock(s) referred above are only for the purpose of disclosure of significant portfolio
changes during the month and should not be construed as recommendation to buy/sell/ hold. The fund manager
may or may not choose to hold these companies/stocks, from time to time. Investors are requested to consult
their financial, tax and other advisors before taking any investment decision(s). Data as on May 31, 2026
| Turnover Ratio (Last 1 year) | 0.90 |
| Standard Deviation | 15.20% |
| Beta | 0.90 |
| Sharpe Ratio# | 0.57 |
| Jenson's Alpha | -0.1026 |
#Risk-free rate assumed to be 5.52% (MIBOR as on 29-05-2026) - Source: www.mmda.org
Note: As per AMFI guidelines for factsheet, the ratios are calculated based on month rolling returns
for last 3 years. Data as on May 29, 2026
^Benchmark ^^Additional Benchmark. CAGR – Compounded Annual Growth Rate. Inception/Allotment date: 30-Dec-19.
Past performance may or may not be sustained in future and should not be used as a basis of comparison with other investments.
Since inception returns of the scheme is calculated on face value of Rs. 10 invested at inception. The performance details provided above are of Growth Option under Regular Plan. Different Plans i.e Regular Plan and Direct Plan under the scheme has different expense structure. *Based on standard investment of Rs. 10,000 made at the beginning of the relevant period. Mr. Neelesh Dhamnaskar is managing this scheme since February 16, 2026.
^Benchmark ^^Additional Benchmark. CAGR – Compounded Annual Growth Rate. Inception/Allotment date: 30-Dec-19.
Past performance may or may not be sustained in future and should not be used as a basis of comparison with other investments. Returns greater than 1 year period are compounded annualized. For SIP returns, monthly investment of equal amounts invested on the 1st business day of every month has been considered. CAGR Returns (%) are computed after accounting for the cash flow by using the XIRR method (investment internal rate of return).
^Benchmark CAGR – Compounded Annual Growth Rate.
Past performance may or may not be sustained in future and should not be used as a basis of comparison with other investments.
The performance details provided above are of Growth Option under Regular Plan. Different Plans i.e Regular Plan and Direct Plan under the scheme has different expense structure. Ms. Kirti Dalvi manages 5 schemes each of Mahindra Manulife Mutual Fund. Mr. Neelesh Dhamnaskar manages 6 schemes each of Mahindra Manulife Mutual Fund. The performance data for the schemes which have not completed one year has not been provided.
Note: The performance data of Mahindra Manulife Innovation Opportunities Fund has not been provided as the scheme has not completed 1 year since inception. The said Scheme is managed by Ms. Kirti Dalvi & Mr. Renjith Sivaram Radhakrishnan.
Note: Performance as on May 29,2026.
Note: As May 30 & 31, 2026 were non-business days, the schemes returns disclosed above is as on May 29, 2026.
This product is suitable for investors who are seeking*:
• Long term wealth creation and
income;
• Investment predominantly in equity
and equity related securities of large
and mid cap companies.

*Investors should consult their financial advisers if in doubt about whether the product is suitable for them.